Back to 
JONES FINANCIAL COMPANIES LLLP
JONES FINANCIAL COMPANIES LLLP
BCLI3 quarters
Position history for JONES FINANCIAL COMPANIES LLLP's holdings in BrainStorm Cell Therapeutics In
No. Jones Financial Companies exited its BCLI (BrainStorm Cell Therapeutics in) position in Q3 2025. Its Q2 2025 13F listed 216 shares worth $229. Jones Financial Companies first reported BCLI in Q1 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$257
Total Shares Change
-216
Quarter-by-Quarter History
Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.